CUTTING EDGE SCIENCE
ABOUT
Hylomorph is a Medtech Startup company, spin-off of the Swiss Federal Institute of Technology.
We specialize in cutting-edge combination of micro-engineering and biotechnology into innovative biomaterials for healthcare products.
Hylomorph's core technology optimizes the interface between implantable medical devices and the biological tissues.
Our headquarter is based at Technopark Zurich, in the heart of Switzerland.
Curious to know more about what we do? Click below and listen to Hylomorph CEO, Dr. Simone Bottan.
TEAM
Credits: Lichtsteiner Foundation
Simone Bottan
CHIEF EXECUTIVE OFFICER
Francesco Robotti
CHIEF OPERATING OFFICER
Aldo Ferrari
CHIEF SCIENTIFIC OFFICER
Sonia Schmocker
CHIEF REGULATORY & QUALITY OFFICER
Sebastian Cavalli
QUALITY SPECIALIST
Georgios Stefopoulos
PROJECT MANAGER
Cherry Malonzo
REGULATORY & QUALITY
WRITER
Eunice Nazario
PRODUCT ENGINEER
BOARD OF DIRECTORS
Gian-Luigi Berini
BOARD CHAIRMAN
Simone Bottan
CHIEF EXECUTIVE OFFICER
Peter Gabriel
BOARD MEMBER
Aldo Ferrari
CHIEF SCIENTIFIC OFFICER
AWARDS AND SUPPORT
Co-funded by the Horizon 2020 programme of the European Union